Fosun International LTD Chemo Centryx, Inc. Transaction History

Fosun International LTD

$106 Million
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 12, 2019	SELL	$6.47 - $8.96 $832,281 - $1.15 Million	-128,637 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$8.31 - $14.85 $306,314 - $547,385	36,861 Added 40.16%	128,637 $1.15 Million
Q1 2019 May 10, 2019	SELL	$10.01 - $13.89 $92,092 - $127,788	-9,200 Reduced 9.11%	91,776 $1.22 Million
Q4 2018 Jan 31, 2019	SELL	$9.15 - $12.26 $531,377 - $711,987	-58,074 Reduced 36.51%	100,976 $1.06 Million
Q3 2018 Nov 09, 2018	BUY	$10.49 - $13.72 $1.67 Million - $2.18 Million	159,050 New	159,050 $1.72 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.